New Obesity Findings Has Been Reported by Investigators at University of Colorado (Progress and challenges in anti-obesity pharmacotherapy)
By a
The news correspondents obtained a quote from the research from the
According to the news reporters, the research concluded: "Although few promising antiobesity medications are in the drug-development pipeline, the most promising drugs are novel molecules that are co-agonists for multiple gut hormones including GLP-1, glucagon, and gastric inhibitory peptide."
For more information on this research see: Progress and challenges in anti-obesity pharmacotherapy. Lancet Diabetes & Endocrinology, 2018;6(3):237-248. Lancet Diabetes & Endocrinology can be contacted at:
Our news journalists report that additional information may be obtained by contacting
The direct object identifier (DOI) for that additional information is: https://doi.org/10.1016/S2213-8587%2817%2930236-X. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.
Keywords for this news article include:
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2018, NewsRx LLC
Medicaid work-requirement bill heads to Tennessee Gov. Bill Haslam
Mayor in two-car crash; wife, other driver injured
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News